News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Chandler Park: Gleason 3+3=6 should NOT be considered a ‘cancer’
Photo of Chandler Park taken from providers.nortonhealthcare.com
Jan 30, 2024, 16:13

Chandler Park: Gleason 3+3=6 should NOT be considered a ‘cancer’

Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on X/Twitter:

“Gleason 3+3=6 should NOT be considered a ‘cancer’. Great debate by Scott Eggener vs Martin Gleave.
LIVE ASCO GU24 poll results below.”

Source: Chandler Park/X

ASCO ASCO GU24 cancer Chandler Park Gleason 6 Martin Gleave OncoDaily Oncology prostate cancer Scott Eggener
Insight
Jul 26, 2024, 19:39
Andrea Necchi: Results from the ECHO-307/KEYNOTE-672 study
Blog
Jul 26, 2024, 19:39
The Weaponization of Professionalism Against Physicians of Color - Florez Lab
Blog
Jul 26, 2024, 19:38
Join the SIOP CONNECT Annual Congress Forum
Blog
Jul 26, 2024, 19:38
Making a difference in the fight against cancer in Kigali - City Cancer Challenge
Blog
Jul 26, 2024, 19:37
Rafeh Naqash: An absolute pleasure working with the JCO Precision Oncology as social media editor
Blog
Jul 26, 2024, 19:37
Chan Cheah: Danish observational study on MAIC of R‐CHOP vs R‐CHOEP for young patients with high‐risk DLBCL
Blog
Jul 26, 2024, 19:34
Arturo LoAIza-Bonilla: Excited to join Total Health as a speaker at the upcoming 2024 ASCO Direct Philadelphia Conference
Insight
Jul 26, 2024, 15:32
Piotr Wysocki: Physical exercise - a new, promising neoadjuvant treatment modality in prostate cancer?
Blog
Jul 26, 2024, 15:20
The interchangeability of PD-L1 scoring systems and assays in gastroesophageal cancer - EORTC
Insight
Jul 26, 2024, 15:14
Francisco Esteva: Bariatric surgery could lower breast cancer risk in women battling obesity
Blog
Jul 26, 2024, 15:14
Oncology research program by National Comprehensive Cancer Network
Insight
Jul 26, 2024, 15:10
ASCO's rapid guideline update for the management of stage III NSCLC